Neutral impactIPO
Paras Healthcare IPO Day 3: Check GMP, subscription status and key details
Economic Times 1 hr ago·23 Oct 2026, 4:20 am
Paras Healthcare’s Rs 1,450 crore initial public offering (IPO) has reached its final day of subscription. The issue, which allows retail investors to buy shares at a fixed price, has seen strong interest from this specific segment, with the quota being fully subscribed. However, demand from institutional investors appears to be weaker, resulting in a muted overall response to the offer.
The grey market premium (GMP) of around 2% suggests that the stock may list at a slight premium to its issue price. For investors, this indicates a modest opening on the listing day. The key takeaway is that while retail participation is robust, the lack of strong institutional support might limit the immediate upside potential for the stock once it starts trading on the exchanges.
Investors should monitor the final subscription numbers and the GMP trend in the coming days. The listing performance will depend on how the stock is received by the broader market and whether the company can justify its valuation. It is important to note that the grey market is an unofficial indicator and does not guarantee listing gains.
Key takeaways
- Category: IPO.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
